Antigen discovery and tuberculosis vaccine development in the post-genomic era

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 9, 2001, Pages 643-647

  Skjot R L V ^a   Agger, E M ^a   Andersen, P ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BCG VACCINE; NUCLEOTIDE;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; GENETIC ORGANIZATION; GENETIC SCREENING; GENOME; HUMAN; MULTIGENE FAMILY; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; PROTEIN FAMILY; SEQUENCE HOMOLOGY; TUBERCULOSIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; GENOME, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0012314060     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110026971     Document Type: Article

References (43)

1. Tuberculosis into the next century
2. Protective effect of BCG in experimental tuberculosis
3. Pathogenesis of experimental tuberculosis in animal models
4. Variation in protection by BCG: Implications of and for heterologous immunity
5. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family
6. Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis
7. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis
8. Proteins released from Mycobacterium tuberculosis during growth
9. T cell response to Mycobacterium tuberculosis
10. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins
11. Immunization of mice with mycobacterial culture filtrate proteins
12. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis
13. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis
14. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis
15. Predominant recognition of the ESAT-6 protein in the first phase of infection with Mycobacterium bovis in cattle
16. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis
17. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
18. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)
19. Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells
20. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice
21. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis
22. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig
23. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis
24. Comparative evaluation of low molecular mass T-cell antigens from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant
25. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides
26. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis
27. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences
28. The immunogenicity of single and combination DNA vaccines against tuberculosis
29. ESAT-6 subunit vaccination against Mycobacterium tuberculosis
30. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen
31. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of Ag85B and ESAT-6
32. An esat-6 knockout mutant of Mycobacterium bovis produced by allelic exchange will be useful for development of a live tuberculosis vaccine
33. Negligible genetic diversity of mycobacterium tuberculosis host immune system protein targets: Evidence of limited selective pressure
34. Circumsporozoite protein genes of malaria parasites (Plasmodium spp.): Evidence for positive selection on immunogenic regions
35. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection
36. Expression and immunogenecity of Mycobacterium tuberculosis antigen 85 by DNA vaccination
37. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines
38. Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG
39. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis
40. Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection
41. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis
42. Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis
43. Isolation, purification and immunological characterization of novel low molecular weight protein antigen CFP 6 from culture filtrate of M. tuberculosis